Defining the Transcriptional and Cellular Landscape of Type 1 Diabetes in the NOD Mouse

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Carrero, Javier A ^a   Calderon, Boris ^a   Towfic, Fadi ^b   Artyomov, Maxim N ^a   Unanue, Emil R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Immuneering Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CD45 ANTIGEN; CXCL9 CHEMOKINE; GAMMA INTERFERON; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; MYOGENIC FACTOR; RAG1 PROTEIN; TRANSCRIPTION FACTOR RUNX1; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BINDING SITE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CHRONOLOGY; CONTROLLED STUDY; CXCL9 GENE; DIABETOGENESIS; DISEASE COURSE; DOWN REGULATION; FEMALE; GBP2 GENE; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GLYCAM1 GENE; ICAM1 GENE; IFN BETA GENE; IFN GAMMA GENE; IFNA GENE; IFNB GENE; IFNG GENE; IMMUNOGLOBULIN DEPOSITION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MOLECULAR DYNAMICS; MOUSE; MYF1 GENE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RTP4 GENE; RUNX1 GENE; UPREGULATION; VCAM1 GENE;

ANIMALS; CELL CYCLE; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; HOMEODOMAIN PROTEINS; INTERFERON TYPE I; ISLETS OF LANGERHANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; MYELOID CELLS; PROTEIN INTERACTION MAPS; SPECIES SPECIFICITY; T-LYMPHOCYTES; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 84875451200     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059701     Document Type: Article

References (60)

1. Todd JA, (2010) Etiology of type 1 diabetes. Immunity 32: 457-467.
2. Suri A, Walters JJ, Gross ML, Unanue ER, (2005) Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity. J Clin Invest 115: 2268-2276.
3. Santamaria P, (2010) The long and winding road to understanding and conquering type 1 diabetes. Immunity 32: 437-445.
4. Eisenbarth GS, (1986) Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314: 1360-1368.
5. Wicker LS, Todd JA, Peterson LB, (1995) Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 13: 179-200.
6. Todd JA, Bell JI, McDevitt HO, (1987) HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599-604.
7. Redondo MJ, Jeffrey J, Fain PR, Eisenbarth GS, Orban T, (2008) Concordance for islet autoimmunity among monozygotic twins. N Engl J Med 359: 2849-2850.
8. Lehuen A, Diana J, Zaccone P, Cooke A, (2010) Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol 10: 501-513.
9. Poirot L, Benoist C, Mathis D, (2004) Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. Proc Natl Acad Sci U S A 101: 8102-8107.
10. Juhl K, Sarkar SA, Wong R, Jensen J, Hutton JC, (2008) Mouse pancreatic endocrine cell transcriptome defined in the embryonic Ngn3-null mouse. Diabetes 57: 2755-2761.
11. Matos M, Park R, Mathis D, Benoist C, (2004) Progression to islet destruction in a cyclophosphamide-induced transgenic model: a microarray overview. Diabetes 53: 2310-2321.
12. Calderon B, Carrero JA, Miller MJ, Unanue ER, (2011) Entry of diabetogenic T cells into islets induces changes that lead to amplification of the cellular response. Proc Natl Acad Sci U S A 108: 1567-1572.
13. Vukkadapu SS, Belli JM, Ishii K, Jegga AG, Hutton JJ, et al. (2005) Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to autoimmune diabetes of the NOD mouse. Physiol Genomics 21: 201-211.
14. Li Q, Xu B, Michie SA, Rubins KH, Schreriber RD, et al. (2008) Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. Proc Natl Acad Sci U S A 105: 12439-12444.
15. Heng TS, Painter MW, (2008) Immunological Genome Project C (2008) The Immunological Genome Project: networks of gene expression in immune cells. Nat Immunol 9: 1091-1094.
16. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, et al. (2006) GenePattern 2.0. Nat Genet 38: 500-501.
17. Calderon B, Unanue ER, (2012) Antigen presentation events in autoimmune diabetes. Curr Opin Immunol 24: 119-128.
18. Calderon B, Carrero JA, Miller MJ, Unanue ER, (2011) Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans. Proc Natl Acad Sci U S A 108: 1561-1566.
19. Liu SY, Sanchez DJ, Aliyari R, Lu S, Cheng G, (2012) Systematic identification of type I and type II interferon-induced antiviral factors. Proc Natl Acad Sci U S A 109: 4239-4244.
20. Ringner M, (2008) What is principal component analysis? Nat Biotechnol 26: 303-304.
21. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
22. Tabas-Madrid D, Nogales-Cadenas R, Pascual-Montano A (2012) GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res.
23. Zambelli F, Pesole G, Pavesi G, (2009) Pscan: finding over-represented transcription factor binding site motifs in sequences from co-regulated or co-expressed genes. Nucleic Acids Res 37: W247-252.
24. Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, et al. (1999) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 27: 29-34.
25. Calderon B, Suri A, Miller MJ, Unanue ER, (2008) Dendritic cells in islets of Langerhans constitutively present beta cell-derived peptides bound to their class II MHC molecules. Proc Natl Acad Sci U S A 105: 6121-6126.
26. Yin N, Xu J, Ginhoux F, Randolph GJ, Merad M, et al. (2012) Functional specialization of islet dendritic cell subsets. J Immunol 188: 4921-4930.
27. Melli K, Friedman RS, Martin AE, Finger EB, Miao G, et al. (2009) Amplification of autoimmune response through induction of dendritic cell maturation in inflamed tissues. J Immunol 182: 2590-2600.
28. Yokoyama WM, Kehn PJ, Cohen DI, Shevach EM, (1990) Chromosomal location of the Ly-49 (A1, YE1/48) multigene family. Genetic association with the NK 1.1 antigen. J Immunol 145: 2353-2358.
29. Benita Y, Cao Z, Giallourakis C, Li C, Gardet A, et al. (2010) Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor. Blood 115: 5376-5384.
30. Fu W, Wojtkiewicz G, Weissleder R, Benoist C, Mathis D, (2012) Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imaging. Nat Immunol 13: 361-368.
31. Taniguchi T, Takaoka A, (2001) A weak signal for strong responses: interferon-alpha/beta revisited. Nat Rev Mol Cell Biol 2: 378-386.
32. Gough DJ, Messina NL, Clarke CJ, Johnstone RW, Levy DE, (2012) Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36: 166-174.
33. Hoglund P, Mintern J, Waltzinger C, Heath W, Benoist C, et al. (1999) Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 189: 331-339.
34. Gagnerault MC, Luan JJ, Lotton C, Lepault F, (2002) Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J Exp Med 196: 369-377.
35. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, et al. (2008) Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455: 1109-1113.
36. Gilliet M, Cao W, Liu YJ, (2008) Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8: 594-606.
37. Mathis D, Vence L, Benoist C, (2001) beta-Cell death during progression to diabetes. Nature 414: 792-798.
38. Baccala R, Hoebe K, Kono DH, Beutler B, Theofilopoulos AN, (2007) TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med 13: 543-551.
39. Huang X, Yuang J, Goddard A, Foulis A, James RF, et al. (1995) Interferon expression in the pancreases of patients with type I diabetes. Diabetes 44: 658-664.
40. Huang X, Hultgren B, Dybdal N, Stewart TA, (1994) Islet expression of interferon-alpha precedes diabetes in both the BB rat and streptozotocin-treated mice. Immunity 1: 469-478.
41. Fujioka T, Honda M, Yoshizaki T, Ogawa M, Matsuno H, et al. (2010) A case of type 1 diabetes onset and recurrence of Graves' disease during pegylated interferon-alpha plus ribavirin treatment for chronic hepatitis C. Intern Med. 49: 1987-1990.
42. Stewart TA, Hultgren B, Huang X, Pitts-Meek S, Hully J, et al. (1993) Induction of type I diabetes by interferon-alpha in transgenic mice. Science 260: 1942-1946.
43. Chakrabarti D, Hultgren B, Stewart TA, (1996) IFN-alpha induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2. J Immunol 157: 522-528.
44. Heinig M, Petretto E, Wallace C, Bottolo L, Rotival M, et al. (2010) A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature 467: 460-464.
45. Theofilopoulos AN, Baccala R, Beutler B, Kono DH, (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23: 307-336.
46. Darce J, Rudra D, Li L, Nishio J, Cipolletta D, et al. (2012) An N-terminal mutation of the foxp3 transcription factor alleviates arthritis but exacerbates diabetes. Immunity 36: 731-741.
47. Bettini ML, Pan F, Bettini M, Finkelstein D, Rehg JE, et al. (2012) Loss of epigenetic modification driven by the foxp3 transcription factor leads to regulatory T cell insufficiency. Immunity 36: 717-730.
48. Tang Q, Adams JY, Penaranda C, Melli K, Piaggio E, et al. (2008) Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28: 687-697.
49. Feuerer M, Shen Y, Littman DR, Benoist C, Mathis D, (2009) How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity 31: 654-664.
50. Calderon B, Suri A, Pan XO, Mills JC, Unanue ER, (2008) IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes. J Immunol 181: 6964-6974.
51. Mori Y, Kodaka T, Kato T, Kanagawa EM, Kanagawa O, (2009) Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development. Int Immunol 21: 1291-1299.
52. Salvalaggio PR, Deng S, Ariyan CE, Millet I, Zawalich WS, et al. (2002) Islet filtration: a simple and rapid new purification procedure that avoids ficoll and improves islet mass and function. Transplantation 74: 877-879.
53. Li DS, Yuan YH, Tu HJ, Liang QL, Dai LJ, (2009) A protocol for islet isolation from mouse pancreas. Nat Protoc 4: 1649-1652.
54. Lacy PE, Kostianovsky M, (1967) Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35-39.
55. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
56. Johnson WE, Li C, Rabinovic A, (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8: 118-127.
57. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate- a Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B-Methodological 57: 289-300.
58. Wang X, Seed B, (2003) A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 31: e154.
59. Stockinger S, Kastner R, Kernbauer E, Pilz A, Westermayer S, et al. (2009) Characterization of the interferon-producing cell in mice infected with Listeria monocytogenes. PLoS Pathog 5: e1000355.
60. Beisser D, Klau GW, Dandekar T, Muller T, Dittrich MT, (2010) BioNet: an R-Package for the functional analysis of biological networks. Bioinformatics 26: 1129-1130.